mouse anti-human ll37 abs Search Results


93
Novus Biologicals anti hcap 18 ll 37 antibody
Anti Hcap 18 Ll 37 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hcap 18 ll 37 antibody/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
anti hcap 18 ll 37 antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

92
Hycult Biotech anti ll 37 antibody
A–C Detection of LL‐37 expression in the engineered mDASCs by immunofluorescence (A), real‐time quantitative PCR (B), and Western blot (C). Scale bar, 50 μm. BF, bright field. n = 10. Error bars, SEM. D Anti‐Krt5 (red) and anti‐P63 (green) immunostaining of WT‐ and LL‐37‐mDASC colonies. Scale bar, 70 μm. E Stem cell colony‐forming efficiency of WT‐ and LL‐37‐mDASCs during five serial passages. n = 6. Error bars, SD. F Representative 3D organoid culture of mDASCs with expression of type I alveolar cell markers (Aqp5 and Pdpn). Left panels, bright‐field imaging of 3D organoids. Right panels, immunofluorescence of organoid sections. Scale bar, 20 μm. G Co‐culture of bacteria with DASCs shows antimicrobial effects in dose‐dependent manner. Initial additions of PAO1 were 0.1 × , 0.5 × and 1 × 10 4 CFU, respectively. Co‐culture duration, 6 h. n = 4. Error bars, SEM. MOI, multiplicity of infection. H Co‐culture of bacteria with DASCs shows antimicrobial effects in time‐dependent manner. Initial concentration of PAO1 was 1 × 10 4 CFU. MOI = 1. n = 3. Error bars, SEM. I, J Preincubation of cells with <t>anti‐LL‐37</t> antibody, but not IgG control, significantly reduced anti‐PAO1 (I) and anti‐ Escherichia coli (J) effects of LL‐37‐mDASCs. Initial dose of bacteria was 10 3 CFU. Co‐culture duration, 18 h. n = 4 in (I) and n = 3 in (J). Error bars, SEM. Data information: Statistics for graphs: unpaired two‐tailed t ‐test (B), two‐way ANOVA followed by Sidak's test (G, H) and one‐way ANOVA followed by Tukey's test (I, J). * P < 0.05; ** P < 0.01; **** P < 0.0001. Source data are available online for this figure.
Anti Ll 37 Antibody, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ll 37 antibody/product/Hycult Biotech
Average 92 stars, based on 1 article reviews
anti ll 37 antibody - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

90
ELISA SYSTEMS Pty Ltd enzyme-linked immunosorbent assay (elisa) systems
A–C Detection of LL‐37 expression in the engineered mDASCs by immunofluorescence (A), real‐time quantitative PCR (B), and Western blot (C). Scale bar, 50 μm. BF, bright field. n = 10. Error bars, SEM. D Anti‐Krt5 (red) and anti‐P63 (green) immunostaining of WT‐ and LL‐37‐mDASC colonies. Scale bar, 70 μm. E Stem cell colony‐forming efficiency of WT‐ and LL‐37‐mDASCs during five serial passages. n = 6. Error bars, SD. F Representative 3D organoid culture of mDASCs with expression of type I alveolar cell markers (Aqp5 and Pdpn). Left panels, bright‐field imaging of 3D organoids. Right panels, immunofluorescence of organoid sections. Scale bar, 20 μm. G Co‐culture of bacteria with DASCs shows antimicrobial effects in dose‐dependent manner. Initial additions of PAO1 were 0.1 × , 0.5 × and 1 × 10 4 CFU, respectively. Co‐culture duration, 6 h. n = 4. Error bars, SEM. MOI, multiplicity of infection. H Co‐culture of bacteria with DASCs shows antimicrobial effects in time‐dependent manner. Initial concentration of PAO1 was 1 × 10 4 CFU. MOI = 1. n = 3. Error bars, SEM. I, J Preincubation of cells with <t>anti‐LL‐37</t> antibody, but not IgG control, significantly reduced anti‐PAO1 (I) and anti‐ Escherichia coli (J) effects of LL‐37‐mDASCs. Initial dose of bacteria was 10 3 CFU. Co‐culture duration, 18 h. n = 4 in (I) and n = 3 in (J). Error bars, SEM. Data information: Statistics for graphs: unpaired two‐tailed t ‐test (B), two‐way ANOVA followed by Sidak's test (G, H) and one‐way ANOVA followed by Tukey's test (I, J). * P < 0.05; ** P < 0.01; **** P < 0.0001. Source data are available online for this figure.
Enzyme Linked Immunosorbent Assay (Elisa) Systems, supplied by ELISA SYSTEMS Pty Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/enzyme-linked immunosorbent assay (elisa) systems/product/ELISA SYSTEMS Pty Ltd
Average 90 stars, based on 1 article reviews
enzyme-linked immunosorbent assay (elisa) systems - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
OriGene ll37
A–C Detection of LL‐37 expression in the engineered mDASCs by immunofluorescence (A), real‐time quantitative PCR (B), and Western blot (C). Scale bar, 50 μm. BF, bright field. n = 10. Error bars, SEM. D Anti‐Krt5 (red) and anti‐P63 (green) immunostaining of WT‐ and LL‐37‐mDASC colonies. Scale bar, 70 μm. E Stem cell colony‐forming efficiency of WT‐ and LL‐37‐mDASCs during five serial passages. n = 6. Error bars, SD. F Representative 3D organoid culture of mDASCs with expression of type I alveolar cell markers (Aqp5 and Pdpn). Left panels, bright‐field imaging of 3D organoids. Right panels, immunofluorescence of organoid sections. Scale bar, 20 μm. G Co‐culture of bacteria with DASCs shows antimicrobial effects in dose‐dependent manner. Initial additions of PAO1 were 0.1 × , 0.5 × and 1 × 10 4 CFU, respectively. Co‐culture duration, 6 h. n = 4. Error bars, SEM. MOI, multiplicity of infection. H Co‐culture of bacteria with DASCs shows antimicrobial effects in time‐dependent manner. Initial concentration of PAO1 was 1 × 10 4 CFU. MOI = 1. n = 3. Error bars, SEM. I, J Preincubation of cells with <t>anti‐LL‐37</t> antibody, but not IgG control, significantly reduced anti‐PAO1 (I) and anti‐ Escherichia coli (J) effects of LL‐37‐mDASCs. Initial dose of bacteria was 10 3 CFU. Co‐culture duration, 18 h. n = 4 in (I) and n = 3 in (J). Error bars, SEM. Data information: Statistics for graphs: unpaired two‐tailed t ‐test (B), two‐way ANOVA followed by Sidak's test (G, H) and one‐way ANOVA followed by Tukey's test (I, J). * P < 0.05; ** P < 0.01; **** P < 0.0001. Source data are available online for this figure.
Ll37, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ll37/product/OriGene
Average 90 stars, based on 1 article reviews
ll37 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

86
Hycult Biotech cathelicidin
PALA treatment results in the secretion of broad-spectrum AMPs from NHDF that kill ESKAPE pathogens. ( a ) Conditioned supernatants from PALA treated NHDF reduce viability of three pathogens of the ESKAPE family. Triplicate mid-log phase cultures of MRSA, P. aeruginosa , and A. baumannii were supplemented with conditioned supernatants collected from NHDF treated with or without PALA (25 µM, 16 hours) and cfu determined after 2–4 hours. Each symbol shown represents mean values of an independent experiment performed in triplicate. Results representative of 6 independent experiments. Mean ± SD; significance determined by unpaired, 2-tailed, Students t-test; ***p < 0.001, ****p < 0.0001. ( b ) PALA treatment induces the secretion of AMPs from NHDF. AMP levels in conditioned media collected from triplicate cultures of NHDF treated with or without PALA (25 µM, 16 hours) were quantitated by ELISA. Results representative of 6 independent experiments performed. Mean ± SD; significance determined by unpaired, 2-tailed, Students t-test; *p < 0.05, **p < 0.01. ( c ) Transcription of the genes encoding HBD2 ( DEFB4A ), and <t>cathelicidin</t> ( CAMP ) is enhanced by PALA treatment, while transcripts of the gene encoding HBD3 ( DEFB103B ) are not increased. NHDF were treated with or without 25 µM PALA for 16 hours in triplicate and RNA extracted. Transcript levels relative to unstimulated cells were determined by qRT-PCR from three independent experiments. Mean ± SD; significance determined by 2-way ANOVA and Bonferroni multiple comparisons test; *p < 0.05, **p < 0.01.
Cathelicidin, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cathelicidin/product/Hycult Biotech
Average 86 stars, based on 1 article reviews
cathelicidin - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse anti ll 37
PALA treatment results in the secretion of broad-spectrum AMPs from NHDF that kill ESKAPE pathogens. ( a ) Conditioned supernatants from PALA treated NHDF reduce viability of three pathogens of the ESKAPE family. Triplicate mid-log phase cultures of MRSA, P. aeruginosa , and A. baumannii were supplemented with conditioned supernatants collected from NHDF treated with or without PALA (25 µM, 16 hours) and cfu determined after 2–4 hours. Each symbol shown represents mean values of an independent experiment performed in triplicate. Results representative of 6 independent experiments. Mean ± SD; significance determined by unpaired, 2-tailed, Students t-test; ***p < 0.001, ****p < 0.0001. ( b ) PALA treatment induces the secretion of AMPs from NHDF. AMP levels in conditioned media collected from triplicate cultures of NHDF treated with or without PALA (25 µM, 16 hours) were quantitated by ELISA. Results representative of 6 independent experiments performed. Mean ± SD; significance determined by unpaired, 2-tailed, Students t-test; *p < 0.05, **p < 0.01. ( c ) Transcription of the genes encoding HBD2 ( DEFB4A ), and <t>cathelicidin</t> ( CAMP ) is enhanced by PALA treatment, while transcripts of the gene encoding HBD3 ( DEFB103B ) are not increased. NHDF were treated with or without 25 µM PALA for 16 hours in triplicate and RNA extracted. Transcript levels relative to unstimulated cells were determined by qRT-PCR from three independent experiments. Mean ± SD; significance determined by 2-way ANOVA and Bonferroni multiple comparisons test; *p < 0.05, **p < 0.01.
Mouse Anti Ll 37, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti ll 37/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
mouse anti ll 37 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Absolute Biotech Inc mouse anti-human ll37
NETs from SLE patients are enriched in ISG15 and H2B is the main substrate. ISG15 and H2B expression was assessed in spontaneous and LPS induced NETs from SLE patients (n = 6) and healthy controls (n = 3) by indirect immunofluorescence (40X) and confocal microscopy. Spontaneous NETs from a representative SLE patient shows the presence of extracellular ISG15 in the NET ( a ). In contrast to the SLE sample, a representative healthy control image shows the absence of ISG15 in the NET ( b ). Blue (DNA), red (ISG15) and green (H2B). Cumulative data from SLE patients and healthy controls (n = 6 subjects per group) show increased expression of ISG15 in the SLE samples ( c ). In SLE samples, ISG15 and H2B colocalized inside NETs with a high Pearson (R = 0.81) and Costes p value (1.0) in a representative SLE patient ( d ) and boxes represent pooled data (n = 6 subjects per group) that show increased colocalization of SLE samples vs healthy controls ( e ). H2B with ISG15 had the higher colocalization R value compared to other NET proteins such as <t>LL37</t> or HMGB1 (Additional file : Figures S5 and S6). * p < 0.05
Mouse Anti Human Ll37, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-human ll37/product/Absolute Biotech Inc
Average 90 stars, based on 1 article reviews
mouse anti-human ll37 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Innovagen AB cathelicidin peptide ll-37
NETs from SLE patients are enriched in ISG15 and H2B is the main substrate. ISG15 and H2B expression was assessed in spontaneous and LPS induced NETs from SLE patients (n = 6) and healthy controls (n = 3) by indirect immunofluorescence (40X) and confocal microscopy. Spontaneous NETs from a representative SLE patient shows the presence of extracellular ISG15 in the NET ( a ). In contrast to the SLE sample, a representative healthy control image shows the absence of ISG15 in the NET ( b ). Blue (DNA), red (ISG15) and green (H2B). Cumulative data from SLE patients and healthy controls (n = 6 subjects per group) show increased expression of ISG15 in the SLE samples ( c ). In SLE samples, ISG15 and H2B colocalized inside NETs with a high Pearson (R = 0.81) and Costes p value (1.0) in a representative SLE patient ( d ) and boxes represent pooled data (n = 6 subjects per group) that show increased colocalization of SLE samples vs healthy controls ( e ). H2B with ISG15 had the higher colocalization R value compared to other NET proteins such as <t>LL37</t> or HMGB1 (Additional file : Figures S5 and S6). * p < 0.05
Cathelicidin Peptide Ll 37, supplied by Innovagen AB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cathelicidin peptide ll-37/product/Innovagen AB
Average 90 stars, based on 1 article reviews
cathelicidin peptide ll-37 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology cathelicidin ll37
NETs from SLE patients are enriched in ISG15 and H2B is the main substrate. ISG15 and H2B expression was assessed in spontaneous and LPS induced NETs from SLE patients (n = 6) and healthy controls (n = 3) by indirect immunofluorescence (40X) and confocal microscopy. Spontaneous NETs from a representative SLE patient shows the presence of extracellular ISG15 in the NET ( a ). In contrast to the SLE sample, a representative healthy control image shows the absence of ISG15 in the NET ( b ). Blue (DNA), red (ISG15) and green (H2B). Cumulative data from SLE patients and healthy controls (n = 6 subjects per group) show increased expression of ISG15 in the SLE samples ( c ). In SLE samples, ISG15 and H2B colocalized inside NETs with a high Pearson (R = 0.81) and Costes p value (1.0) in a representative SLE patient ( d ) and boxes represent pooled data (n = 6 subjects per group) that show increased colocalization of SLE samples vs healthy controls ( e ). H2B with ISG15 had the higher colocalization R value compared to other NET proteins such as <t>LL37</t> or HMGB1 (Additional file : Figures S5 and S6). * p < 0.05
Cathelicidin Ll37, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cathelicidin ll37/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
cathelicidin ll37 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Wolters Kluwer Health anti-infective secreted cathelicidin (ll37)
NETs from SLE patients are enriched in ISG15 and H2B is the main substrate. ISG15 and H2B expression was assessed in spontaneous and LPS induced NETs from SLE patients (n = 6) and healthy controls (n = 3) by indirect immunofluorescence (40X) and confocal microscopy. Spontaneous NETs from a representative SLE patient shows the presence of extracellular ISG15 in the NET ( a ). In contrast to the SLE sample, a representative healthy control image shows the absence of ISG15 in the NET ( b ). Blue (DNA), red (ISG15) and green (H2B). Cumulative data from SLE patients and healthy controls (n = 6 subjects per group) show increased expression of ISG15 in the SLE samples ( c ). In SLE samples, ISG15 and H2B colocalized inside NETs with a high Pearson (R = 0.81) and Costes p value (1.0) in a representative SLE patient ( d ) and boxes represent pooled data (n = 6 subjects per group) that show increased colocalization of SLE samples vs healthy controls ( e ). H2B with ISG15 had the higher colocalization R value compared to other NET proteins such as <t>LL37</t> or HMGB1 (Additional file : Figures S5 and S6). * p < 0.05
Anti Infective Secreted Cathelicidin (Ll37), supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-infective secreted cathelicidin (ll37)/product/Wolters Kluwer Health
Average 90 stars, based on 1 article reviews
anti-infective secreted cathelicidin (ll37) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Novus Biologicals anti-hcap18 nbp1-76864
NETs from SLE patients are enriched in ISG15 and H2B is the main substrate. ISG15 and H2B expression was assessed in spontaneous and LPS induced NETs from SLE patients (n = 6) and healthy controls (n = 3) by indirect immunofluorescence (40X) and confocal microscopy. Spontaneous NETs from a representative SLE patient shows the presence of extracellular ISG15 in the NET ( a ). In contrast to the SLE sample, a representative healthy control image shows the absence of ISG15 in the NET ( b ). Blue (DNA), red (ISG15) and green (H2B). Cumulative data from SLE patients and healthy controls (n = 6 subjects per group) show increased expression of ISG15 in the SLE samples ( c ). In SLE samples, ISG15 and H2B colocalized inside NETs with a high Pearson (R = 0.81) and Costes p value (1.0) in a representative SLE patient ( d ) and boxes represent pooled data (n = 6 subjects per group) that show increased colocalization of SLE samples vs healthy controls ( e ). H2B with ISG15 had the higher colocalization R value compared to other NET proteins such as <t>LL37</t> or HMGB1 (Additional file : Figures S5 and S6). * p < 0.05
Anti Hcap18 Nbp1 76864, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hcap18 nbp1-76864/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
anti-hcap18 nbp1-76864 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Euro Diagnostica ll-37 peptide (lot ys 5253, eurodiagnostica ab, malmo, sweden)
NETs from SLE patients are enriched in ISG15 and H2B is the main substrate. ISG15 and H2B expression was assessed in spontaneous and LPS induced NETs from SLE patients (n = 6) and healthy controls (n = 3) by indirect immunofluorescence (40X) and confocal microscopy. Spontaneous NETs from a representative SLE patient shows the presence of extracellular ISG15 in the NET ( a ). In contrast to the SLE sample, a representative healthy control image shows the absence of ISG15 in the NET ( b ). Blue (DNA), red (ISG15) and green (H2B). Cumulative data from SLE patients and healthy controls (n = 6 subjects per group) show increased expression of ISG15 in the SLE samples ( c ). In SLE samples, ISG15 and H2B colocalized inside NETs with a high Pearson (R = 0.81) and Costes p value (1.0) in a representative SLE patient ( d ) and boxes represent pooled data (n = 6 subjects per group) that show increased colocalization of SLE samples vs healthy controls ( e ). H2B with ISG15 had the higher colocalization R value compared to other NET proteins such as <t>LL37</t> or HMGB1 (Additional file : Figures S5 and S6). * p < 0.05
Ll 37 Peptide (Lot Ys 5253, Eurodiagnostica Ab, Malmo, Sweden), supplied by Euro Diagnostica, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ll-37 peptide (lot ys 5253, eurodiagnostica ab, malmo, sweden)/product/Euro Diagnostica
Average 90 stars, based on 1 article reviews
ll-37 peptide (lot ys 5253, eurodiagnostica ab, malmo, sweden) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


A–C Detection of LL‐37 expression in the engineered mDASCs by immunofluorescence (A), real‐time quantitative PCR (B), and Western blot (C). Scale bar, 50 μm. BF, bright field. n = 10. Error bars, SEM. D Anti‐Krt5 (red) and anti‐P63 (green) immunostaining of WT‐ and LL‐37‐mDASC colonies. Scale bar, 70 μm. E Stem cell colony‐forming efficiency of WT‐ and LL‐37‐mDASCs during five serial passages. n = 6. Error bars, SD. F Representative 3D organoid culture of mDASCs with expression of type I alveolar cell markers (Aqp5 and Pdpn). Left panels, bright‐field imaging of 3D organoids. Right panels, immunofluorescence of organoid sections. Scale bar, 20 μm. G Co‐culture of bacteria with DASCs shows antimicrobial effects in dose‐dependent manner. Initial additions of PAO1 were 0.1 × , 0.5 × and 1 × 10 4 CFU, respectively. Co‐culture duration, 6 h. n = 4. Error bars, SEM. MOI, multiplicity of infection. H Co‐culture of bacteria with DASCs shows antimicrobial effects in time‐dependent manner. Initial concentration of PAO1 was 1 × 10 4 CFU. MOI = 1. n = 3. Error bars, SEM. I, J Preincubation of cells with anti‐LL‐37 antibody, but not IgG control, significantly reduced anti‐PAO1 (I) and anti‐ Escherichia coli (J) effects of LL‐37‐mDASCs. Initial dose of bacteria was 10 3 CFU. Co‐culture duration, 18 h. n = 4 in (I) and n = 3 in (J). Error bars, SEM. Data information: Statistics for graphs: unpaired two‐tailed t ‐test (B), two‐way ANOVA followed by Sidak's test (G, H) and one‐way ANOVA followed by Tukey's test (I, J). * P < 0.05; ** P < 0.01; **** P < 0.0001. Source data are available online for this figure.

Journal: EMBO Molecular Medicine

Article Title: Genetically engineered distal airway stem cell transplantation protects mice from pulmonary infection

doi: 10.15252/emmm.201810233

Figure Lengend Snippet: A–C Detection of LL‐37 expression in the engineered mDASCs by immunofluorescence (A), real‐time quantitative PCR (B), and Western blot (C). Scale bar, 50 μm. BF, bright field. n = 10. Error bars, SEM. D Anti‐Krt5 (red) and anti‐P63 (green) immunostaining of WT‐ and LL‐37‐mDASC colonies. Scale bar, 70 μm. E Stem cell colony‐forming efficiency of WT‐ and LL‐37‐mDASCs during five serial passages. n = 6. Error bars, SD. F Representative 3D organoid culture of mDASCs with expression of type I alveolar cell markers (Aqp5 and Pdpn). Left panels, bright‐field imaging of 3D organoids. Right panels, immunofluorescence of organoid sections. Scale bar, 20 μm. G Co‐culture of bacteria with DASCs shows antimicrobial effects in dose‐dependent manner. Initial additions of PAO1 were 0.1 × , 0.5 × and 1 × 10 4 CFU, respectively. Co‐culture duration, 6 h. n = 4. Error bars, SEM. MOI, multiplicity of infection. H Co‐culture of bacteria with DASCs shows antimicrobial effects in time‐dependent manner. Initial concentration of PAO1 was 1 × 10 4 CFU. MOI = 1. n = 3. Error bars, SEM. I, J Preincubation of cells with anti‐LL‐37 antibody, but not IgG control, significantly reduced anti‐PAO1 (I) and anti‐ Escherichia coli (J) effects of LL‐37‐mDASCs. Initial dose of bacteria was 10 3 CFU. Co‐culture duration, 18 h. n = 4 in (I) and n = 3 in (J). Error bars, SEM. Data information: Statistics for graphs: unpaired two‐tailed t ‐test (B), two‐way ANOVA followed by Sidak's test (G, H) and one‐way ANOVA followed by Tukey's test (I, J). * P < 0.05; ** P < 0.01; **** P < 0.0001. Source data are available online for this figure.

Article Snippet: 1 × 10 4 cells per well) within culture medium without antibiotics and FBS were pre‐incubated with 1 μg/ml anti‐LL‐37 antibody (HM2070, Hycult biotech) or mouse isotype antibody control (B30010M, Abmart) for 2 h, and then co‐cultured with P. aeruginosa or E. coli in a humidified CO 2 incubator.

Techniques: Expressing, Immunofluorescence, Real-time Polymerase Chain Reaction, Western Blot, Immunostaining, Imaging, Co-Culture Assay, Infection, Concentration Assay, Two Tailed Test

A Cell growth curve of WT‐ and LL‐37‐mDASCs was measured by MTT assay. n = 3–5. Error bars, SD. B Soft agar assay of WT‐ and LL‐37‐mDASCs. Mouse melanoma cell line was included as a positive control. C Histogram showed that LL‐37‐mDASCs conditioned medium (CM) had potent growth inhibitory effect on PAO1. Initial addition of PAO1 was 1 × 10 4 CFU. n = 5. Error bars, SEM. D Histogram shows that LL‐37‐mDASCs CM had potent growth inhibitory effect on Escherichia coli . Initial addition of E. coli was 1 × 10 4 CFU. n = 3. Error bars, SEM. E Clone formation unit assay of E. coli following incubation with indicated cellular CM. F Preincubation of CM with anti‐LL‐37 antibody, but not mouse IgG, reduced the antimicrobial effect of LL‐37‐mDASCs against E. coli . n = 3. Error bars, SEM. Data information: Statistics for graphs: one‐way ANOVA followed by Tukey's test. * P < 0.05; *** P < 0.001.

Journal: EMBO Molecular Medicine

Article Title: Genetically engineered distal airway stem cell transplantation protects mice from pulmonary infection

doi: 10.15252/emmm.201810233

Figure Lengend Snippet: A Cell growth curve of WT‐ and LL‐37‐mDASCs was measured by MTT assay. n = 3–5. Error bars, SD. B Soft agar assay of WT‐ and LL‐37‐mDASCs. Mouse melanoma cell line was included as a positive control. C Histogram showed that LL‐37‐mDASCs conditioned medium (CM) had potent growth inhibitory effect on PAO1. Initial addition of PAO1 was 1 × 10 4 CFU. n = 5. Error bars, SEM. D Histogram shows that LL‐37‐mDASCs CM had potent growth inhibitory effect on Escherichia coli . Initial addition of E. coli was 1 × 10 4 CFU. n = 3. Error bars, SEM. E Clone formation unit assay of E. coli following incubation with indicated cellular CM. F Preincubation of CM with anti‐LL‐37 antibody, but not mouse IgG, reduced the antimicrobial effect of LL‐37‐mDASCs against E. coli . n = 3. Error bars, SEM. Data information: Statistics for graphs: one‐way ANOVA followed by Tukey's test. * P < 0.05; *** P < 0.001.

Article Snippet: 1 × 10 4 cells per well) within culture medium without antibiotics and FBS were pre‐incubated with 1 μg/ml anti‐LL‐37 antibody (HM2070, Hycult biotech) or mouse isotype antibody control (B30010M, Abmart) for 2 h, and then co‐cultured with P. aeruginosa or E. coli in a humidified CO 2 incubator.

Techniques: MTT Assay, Soft Agar Assay, Positive Control, Incubation

PALA treatment results in the secretion of broad-spectrum AMPs from NHDF that kill ESKAPE pathogens. ( a ) Conditioned supernatants from PALA treated NHDF reduce viability of three pathogens of the ESKAPE family. Triplicate mid-log phase cultures of MRSA, P. aeruginosa , and A. baumannii were supplemented with conditioned supernatants collected from NHDF treated with or without PALA (25 µM, 16 hours) and cfu determined after 2–4 hours. Each symbol shown represents mean values of an independent experiment performed in triplicate. Results representative of 6 independent experiments. Mean ± SD; significance determined by unpaired, 2-tailed, Students t-test; ***p < 0.001, ****p < 0.0001. ( b ) PALA treatment induces the secretion of AMPs from NHDF. AMP levels in conditioned media collected from triplicate cultures of NHDF treated with or without PALA (25 µM, 16 hours) were quantitated by ELISA. Results representative of 6 independent experiments performed. Mean ± SD; significance determined by unpaired, 2-tailed, Students t-test; *p < 0.05, **p < 0.01. ( c ) Transcription of the genes encoding HBD2 ( DEFB4A ), and cathelicidin ( CAMP ) is enhanced by PALA treatment, while transcripts of the gene encoding HBD3 ( DEFB103B ) are not increased. NHDF were treated with or without 25 µM PALA for 16 hours in triplicate and RNA extracted. Transcript levels relative to unstimulated cells were determined by qRT-PCR from three independent experiments. Mean ± SD; significance determined by 2-way ANOVA and Bonferroni multiple comparisons test; *p < 0.05, **p < 0.01.

Journal: Scientific Reports

Article Title: Pyrimidine synthesis inhibition enhances cutaneous defenses against antibiotic resistant bacteria through activation of NOD2 signaling

doi: 10.1038/s41598-018-27012-0

Figure Lengend Snippet: PALA treatment results in the secretion of broad-spectrum AMPs from NHDF that kill ESKAPE pathogens. ( a ) Conditioned supernatants from PALA treated NHDF reduce viability of three pathogens of the ESKAPE family. Triplicate mid-log phase cultures of MRSA, P. aeruginosa , and A. baumannii were supplemented with conditioned supernatants collected from NHDF treated with or without PALA (25 µM, 16 hours) and cfu determined after 2–4 hours. Each symbol shown represents mean values of an independent experiment performed in triplicate. Results representative of 6 independent experiments. Mean ± SD; significance determined by unpaired, 2-tailed, Students t-test; ***p < 0.001, ****p < 0.0001. ( b ) PALA treatment induces the secretion of AMPs from NHDF. AMP levels in conditioned media collected from triplicate cultures of NHDF treated with or without PALA (25 µM, 16 hours) were quantitated by ELISA. Results representative of 6 independent experiments performed. Mean ± SD; significance determined by unpaired, 2-tailed, Students t-test; *p < 0.05, **p < 0.01. ( c ) Transcription of the genes encoding HBD2 ( DEFB4A ), and cathelicidin ( CAMP ) is enhanced by PALA treatment, while transcripts of the gene encoding HBD3 ( DEFB103B ) are not increased. NHDF were treated with or without 25 µM PALA for 16 hours in triplicate and RNA extracted. Transcript levels relative to unstimulated cells were determined by qRT-PCR from three independent experiments. Mean ± SD; significance determined by 2-way ANOVA and Bonferroni multiple comparisons test; *p < 0.05, **p < 0.01.

Article Snippet: AMP levels in tissue homogenates was determined by ELISA for HBD2 (Peprotech, Rocky Hill, NJ), HBD3 (Peprotech), and cathelicidin (LL-37; Hycult, Plymouth Meeting, PA) according to manufacturer’s protocols.

Techniques: Enzyme-linked Immunosorbent Assay, Quantitative RT-PCR

NETs from SLE patients are enriched in ISG15 and H2B is the main substrate. ISG15 and H2B expression was assessed in spontaneous and LPS induced NETs from SLE patients (n = 6) and healthy controls (n = 3) by indirect immunofluorescence (40X) and confocal microscopy. Spontaneous NETs from a representative SLE patient shows the presence of extracellular ISG15 in the NET ( a ). In contrast to the SLE sample, a representative healthy control image shows the absence of ISG15 in the NET ( b ). Blue (DNA), red (ISG15) and green (H2B). Cumulative data from SLE patients and healthy controls (n = 6 subjects per group) show increased expression of ISG15 in the SLE samples ( c ). In SLE samples, ISG15 and H2B colocalized inside NETs with a high Pearson (R = 0.81) and Costes p value (1.0) in a representative SLE patient ( d ) and boxes represent pooled data (n = 6 subjects per group) that show increased colocalization of SLE samples vs healthy controls ( e ). H2B with ISG15 had the higher colocalization R value compared to other NET proteins such as LL37 or HMGB1 (Additional file : Figures S5 and S6). * p < 0.05

Journal: Journal of Translational Medicine

Article Title: Conformational changes in myeloperoxidase induced by ubiquitin and NETs containing free ISG15 from systemic lupus erythematosus patients promote a pro-inflammatory cytokine response in CD4 + T cells

doi: 10.1186/s12967-020-02604-5

Figure Lengend Snippet: NETs from SLE patients are enriched in ISG15 and H2B is the main substrate. ISG15 and H2B expression was assessed in spontaneous and LPS induced NETs from SLE patients (n = 6) and healthy controls (n = 3) by indirect immunofluorescence (40X) and confocal microscopy. Spontaneous NETs from a representative SLE patient shows the presence of extracellular ISG15 in the NET ( a ). In contrast to the SLE sample, a representative healthy control image shows the absence of ISG15 in the NET ( b ). Blue (DNA), red (ISG15) and green (H2B). Cumulative data from SLE patients and healthy controls (n = 6 subjects per group) show increased expression of ISG15 in the SLE samples ( c ). In SLE samples, ISG15 and H2B colocalized inside NETs with a high Pearson (R = 0.81) and Costes p value (1.0) in a representative SLE patient ( d ) and boxes represent pooled data (n = 6 subjects per group) that show increased colocalization of SLE samples vs healthy controls ( e ). H2B with ISG15 had the higher colocalization R value compared to other NET proteins such as LL37 or HMGB1 (Additional file : Figures S5 and S6). * p < 0.05

Article Snippet: Additionally, we used mouse anti-human LL37 (LSBio™) or mouse anti-human HMGB1 ( Thermo Fisher™ ). (Additional file : Figures S5 and S6).

Techniques: Expressing, Immunofluorescence, Confocal Microscopy